Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Miyuki Kato‐Murayama"'
Autor:
Xian-Yang Qin, Yutaka Furutani, Kento Yonezawa, Nobutaka Shimizu, Miyuki Kato-Murayama, Mikako Shirouzu, Yali Xu, Yumiko Yamano, Akimori Wada, Luc Gailhouste, Rajan Shrestha, Masataka Takahashi, Jeffrey W. Keillor, Ting Su, Wenkui Yu, Shinya Fujii, Hiroyuki Kagechika, Naoshi Dohmae, Yohei Shirakami, Masahito Shimizu, Takahiro Masaki, Tomokazu Matsuura, Harukazu Suzuki, Soichi Kojima
Publikováno v:
Cell Death and Disease, Vol 14, Iss 6, Pp 1-15 (2023)
Abstract Transglutaminase 2 (TG2) is a multifunctional protein that promotes or suppresses tumorigenesis, depending on intracellular location and conformational structure. Acyclic retinoid (ACR) is an orally administered vitamin A derivative that pre
Externí odkaz:
https://doaj.org/article/6988d4bd40ae412bb6f755ac1f920c89
Autor:
Tomomi Kimura‐Someya, Miyuki Kato‐Murayama, Kazushige Katsura, Naoki Sakai, Kazutaka Murayama, Kazuharu Hanada, Mikako Shirouzu, Yuichi Someya
Publikováno v:
FEBS Open Bio, Vol 12, Iss 3, Pp 560-570 (2022)
Noroviruses have been identified as major causative agents of acute nonbacterial gastroenteritis in humans. Histo‐blood group antigens (HBGAs) are thought to play a major role among the host cellular factors influencing norovirus infection. Genogro
Externí odkaz:
https://doaj.org/article/334a8259cabc477988a84d5eff4e10d4
Autor:
Kanako Shimizu, Tomonori Iyoda, An Sanpei, Hiroshi Nakazato, Masahiro Okada, Shogo Ueda, Miyuki Kato-Murayama, Kazutaka Murayama, Mikako Shirouzu, Naoko Harada, Michihiro Hidaka, Shin-ichiro Fujii
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Kanako Shimizu et al. identify HLA-A24 high-binding epitopes in the SARS-CoV-2 spike region and investigate their cross-reactivity with CD8+ T cell receptors. These results provide further insight into CD8+ T cell cross-reactivity toward SARS-CoV-2 a
Externí odkaz:
https://doaj.org/article/b7cfecf00c01417f9f7847303e27b7d3
Autor:
Dr. Naomi Ohbayashi, Dr. Kazutaka Murayama, Miyuki Kato‐Murayama, Dr. Mutsuko Kukimoto‐Niino, Dr. Tamami Uejima, Dr. Takayoshi Matsuda, Dr. Noboru Ohsawa, Prof. Shigeyuki Yokoyama, Prof. Hiroshi Nojima, Dr. Mikako Shirouzu
Publikováno v:
ChemistryOpen, Vol 7, Iss 9, Pp 713-719 (2018)
Abstract Gefitinib is the molecular target drug for advanced non‐small‐cell lung cancer. The primary target of gefitinib is the positive mutation of epidermal growth factor receptor, but it also inhibits cyclin G‐associated kinase (GAK). To rev
Externí odkaz:
https://doaj.org/article/1792a4ab9ff142d693f1b4b82f51f702
Autor:
Hiroaki Hamana, Yoshiaki Yasutake, Miyuki Kato-Murayama, Toshiaki Hosaka, Mikako Shirouzu, Shin-ichi Sakasegawa, Daisuke Sugimori, Kazutaka Murayama
Publikováno v:
Bioscience, Biotechnology, and Biochemistry. 87:74-81
Lysoplasmalogen-specific phospholipase D (LyPls-PLD) hydrolyzes choline lysoplasmalogen to choline and 1-(1-alkenyl)-sn-glycero-3-phosphate. Mutation of F211 to leucine altered its substrate specificity from lysoplasmalogen to 1-O-hexadecyl-2-hydroxy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::347dcc6be424bba294a018b0ae49b86d
https://doi.org/10.1093/bbb/zbac169
https://doi.org/10.1093/bbb/zbac169
Autor:
Kalarickal V. Dileep, Minoru Yoshida, Divya M. Sivaraman, Akiko Nakata, Miyuki Kato-Murayama, Akihiro Ito, Kam Y. J. Zhang, Jay W. Shin, Mikako Shirouzu, Naoki Sakai, Kentaro Ihara
Publikováno v:
International Journal of Biological Macromolecules. 170:415-423
Alzheimer's disease (AD), a common chronic neurodegenerative disease, has become a major public health concern. Despite years of research, therapeutics for AD are limited. Overexpression of secretory glutaminyl cyclase (sQC) in AD brain leads to the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36cc1608d4d8f5c0ddaa2862df99f5ea
https://doi.org/10.1016/j.ijbiomac.2020.12.118
https://doi.org/10.1016/j.ijbiomac.2020.12.118
Autor:
Tomonori Iyoda, Kanako Shimizu, Michihiro Hidaka, Masahiro Okada, Shin-ichiro Fujii, Shogo Ueda, Naoko Harada, An Sanpei, Mikako Shirouzu, Kazutaka Murayama, Miyuki Kato-Murayama, Hiroshi Nakazato
Publikováno v:
Communications Biology
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
Communications Biology, Vol 4, Iss 1, Pp 1-13 (2021)
SARS-CoV-2-specific CD8+ T cells are scarce but detectable in unexposed healthy donors (UHDs). It remains unclear whether pre-existing human coronavirus (HCoV)-specific CD8+ T cells are converted to functionally competent T cells cross-reactive to SA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50ada8733bc8f42e00a0814b7032473d
http://europepmc.org/articles/PMC8640030
http://europepmc.org/articles/PMC8640030
Autor:
Hiroaki Hamana, Yoshiaki Yasutake, Miyuki Kato-Murayama, Toshiaki Hosaka, Mikako Shirouzu, Shin-ichi Sakasegawa, Daisuke Sugimori, Kazutaka Murayama
Publikováno v:
Bioscience, Biotechnology & Biochemistry; Jan2023, Vol. 87 Issue 1, p74-81, 8p
Autor:
Miyuki Kato-Murayama, Tamami Uejima, Naomi Ohbayashi, Hiroshi Nojima, Mutsuko Kukimoto-Niino, Shigeyuki Yokoyoma, Noboru Ohsawa, Kazutaka Murayama, Mikako Shirouzu, Takayoshi Matsuda
Publikováno v:
ChemistryOpen, Vol 7, Iss 9, Pp 713-719 (2018)
ChemistryOpen
ChemistryOpen
Gefitinib is the molecular target drug for advanced non‐small‐cell lung cancer. The primary target of gefitinib is the positive mutation of epidermal growth factor receptor, but it also inhibits cyclin G‐associated kinase (GAK). To reveal the m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2272832e711352642fc0dcbcd43db963
https://doaj.org/article/1792a4ab9ff142d693f1b4b82f51f702
https://doaj.org/article/1792a4ab9ff142d693f1b4b82f51f702
Autor:
Ami Sotokawauchi1, Miyuki Kato-Murayama2, Kazutaka Murayama2,3, Toshiaki Hosaka2, Iori Maeda4, Michio Onjo5, Noboru Ohsawa2, Dai-Ichiro Kato1, Kazunari Arima1 arima@sci.kagoshima-u.ac.jp, Mikako Shirouzu2 mikako.shirouzu@riken.jp
Publikováno v:
Journal of Biochemistry. Jan2017, Vol. 161 Issue 1, p45-53. 9p.